Strategies for DNA vaccine delivery (Q36316818)

13 August 2017

1 reference

title

Strategies for DNA vaccine delivery (English)

1 reference

13 August 2017

H Oya Alpar

1 reference

13 August 2017

Irene Papanicolaou

series ordinal

1 reference

13 August 2017

Vincent W Bramwell

series ordinal

1 reference

13 August 2017

language of work or name

English

0 references

publication date

1 September 2005

1 reference

Expert Opinion on Drug Delivery

13 August 2017

published in

1 reference

13 August 2017

1 reference

13 August 2017

1 reference

13 August 2017

page(s)

829-842

1 reference

Vaccines in historic evolution and perspective: a narrative of vaccine discoveries

13 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2.5.829

Symposium on smallpox eradication. Smallpox eradication-a narrative account

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2.5.829

Vaccines, coming of age after 200 years

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2.5.829

Live attenuated vaccines against influenza; an historical review

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2.5.829

The efficacy of whole cell pertussis immunisation: collected data on a vaccine produced in France

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2.5.829

Human hepatitis B vaccine from recombinant yeast

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2.5.829

Synthesis and assembly of hepatitis B virus surface antigen particles in yeast

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2.5.829

Production of recombinant subunit vaccines: protein immunogens, live delivery systems and nucleic acid vaccines

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2.5.829

Current status of DNA vaccines and their route of administration

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2.5.829

The vacuolating virus, S.V. 40

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2.5.829

Particulate delivery systems for biodefense subunit vaccines

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2.5.829

Particulate delivery systems for vaccines

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2.5.829

New approaches in vaccine development

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2.5.829

Towards multifunctional synthetic vectors

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2.5.829

Direct gene transfer into mouse muscle in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2.5.829

Genetic immunization is a simple method for eliciting an immune response

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2.5.829

Adjuvant formulations and delivery systems for DNA vaccines

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2.5.829

DNA vaccines: a novel approach to immunization.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2.5.829

Limitations of plasmid vaccines to complex viruses: selected myxoma virus antigens as DNA vaccines were not protective

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2.5.829

Technical and regulatory hurdles for DNA vaccines

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2.5.829

Electroporation for gene transfer to skeletal muscles: current status

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2.5.829

Protein expression in vivo by injection of polynucleotides

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2.5.829

Codon optimization and ubiquitin conjugation of human immunodeficiency virus-1 Tat lead to enhanced cell-mediated immune responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2.5.829

Rapid evolution of a protein in vitro by DNA shuffling

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2.5.829

Improved green fluorescent protein by molecular evolution using DNA shuffling

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2.5.829

Evolution of a cytokine using DNA family shuffling

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2.5.829

Directed evolution: the 'rational' basis for 'irrational' design.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2.5.829

Noncytopathic flavivirus replicon RNA-based system for expression and delivery of heterologous genes

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2.5.829

Cancer therapy using a self-replicating RNA vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2.5.829

Stable high-level expression of heterologous genes in vitro and in vivo by noncytopathic DNA-based Kunjin virus replicon vectors

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2.5.829

DNA vaccination of mice against rabies virus: effects of the route of vaccination and the adjuvant monophosphoryl lipid A (MPL).

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2.5.829

Topical delivery of imiquimod to a mouse model as a novel adjuvant for human immunodeficiency virus (HIV) DNA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2.5.829

Microparticles for the delivery of DNA vaccines

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2.5.829

Biodegradable mucoadhesive particulates for nasal and pulmonary antigen and DNA delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2.5.829

Powder and particle-mediated approaches for delivery of DNA and protein vaccines into the epidermis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2.5.829

Biodegradable poly(lactic-co-glycolic acid) microparticles for injectable delivery of vaccine antigens

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2.5.829

Formulation aspects of biodegradable polymeric microspheres for antigen delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2.5.829

Polymers for the sustained release of proteins and other macromolecules

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2.5.829

A single-step immunization by sustained antigen release

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2.5.829

DNA-loaded biodegradable microparticles as vaccine delivery systems and their interaction with dendritic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2.5.829

Biodegradation and biocompatibility of PLA and PLGA microspheres

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2.5.829

Mechanisms of polymer degradation and erosion

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2.5.829

The use of bioabsorbable implants in the spine

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2.5.829

Biodegradable polyester elastomers in tissue engineering

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2.5.829

Jet milling--a new technique for microparticle preparation

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2.5.829

Poly(?-lactide-co-glycolide)-encapsulated plasmid DNA elicits systemic and mucosal antibody responses to encoded protein after oral administration

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2.5.829

Modulation of allergic responses in mice by using biodegradable poly(lactide-co-glycolide) microspheres

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2.5.829

Preparation of liposomes containing factor VIII for oral treatment of haemophilia

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2.5.829

Vaccine entrapment in liposomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2.5.829

Liposome-mediated DNA vaccination: the effect of vesicle composition

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2.5.829

Lipofection: a highly efficient, lipid-mediated DNA-transfection procedure

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2.5.829

A novel cationic liposome reagent for efficient transfection of mammalian cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2.5.829

Mechanism of lipoplex gene delivery in mouse lung: binding and internalization of fluorescent lipid and DNA components

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2.5.829

DNA vaccination against respiratory influenza virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2.5.829

Augmentation of antigen-specific immune responses using DNA-fusogenic liposome vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2.5.829

Plasmid DNA activates murine macrophages to induce inflammatory cytokines in a CpG motif-independent manner by complex formation with cationic liposomes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2.5.829

Formation of virosomes from influenza subunits and liposomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2.5.829

Immune-reconstituted influenza virosome containing CD40L gene enhances the immunological and protective activity of a carcinoembryonic antigen anticancer vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2.5.829

Formulation and in vitro transfection efficiency of poly (D, L-lactide-co-glycolide) microspheres containing plasmid DNA for gene delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2.5.829

Biocompatible stabilizers in the preparation of PLGA nanoparticles: a factorial design study

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2.5.829

Overcoming the inhibitory effect of serum on lipofection by increasing the charge ratio of cationic liposome to DNA

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2.5.829

Encapsulation of plasmid DNA in PLGA-stearylamine microspheres: a comparison of solvent evaporation and spray-drying methods

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2.5.829

Preparation and characterization of cationic PLGA nanospheres as DNA carriers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2.5.829

Cationic microparticles: A potent delivery system for DNA vaccines

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2.5.829

Transport of polymeric nanoparticle gene carriers in gastric mucus

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2.5.829

Liposome/DNA complexes coated with biodegradable PLA improve immune responses to plasmid encoding hepatitis B surface antigen

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2.5.829

Increased resistance of DNA lipoplexes to protein binding in vitro by surface-modification with a multivalent hydrophilic polymer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2.5.829

Oral gene delivery with chitosan--DNA nanoparticles generates immunologic protection in a murine model of peanut allergy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2.5.829

Polysaccharide colloidal particles as delivery systems for macromolecules

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2.5.829

Expression of luciferase in selected organs following delivery of naked and formulated DNA to rainbow trout (Oncorhynchus mykiss) by different routes of administration

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2.5.829

DNA vaccines: protective immunizations by parenteral, mucosal, and gene-gun inoculations

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2.5.829

Trimethylated chitosans as non-viral gene delivery vectors: cytotoxicity and transfection efficiency

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2.5.829

Immunogenic and protective effects of a DNA vaccine for Mycobacterium marinum in fish

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2.5.829

Self-assembled nanoparticles containing hydrophobically modified glycol chitosan for gene delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2.5.829

Immobilization of plasmid DNA in bacterial ghosts.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2.5.829

DNA minigene vaccination for adjuvant neuroblastoma therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2.5.829

Bacteria as DNA vaccine carriers for genetic immunization

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2.5.829

Attenuated salmonella and Shigella as carriers for DNA vaccines

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2.5.829

Gram-positive and Gram-negative bacteria as carrier systems for DNA vaccines

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2.5.829

From evil to good: a cytolysin in vaccine development.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2.5.829

Recent advances with recombinant bacterial vaccine vectors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2.5.829

Aromatic-dependent salmonella as anti-bacterial vaccines and as presenters of heterologous antigens or of DNA encoding them

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2.5.829

Immune response in guinea pigs vaccinated with DNA vaccine of foot-and-mouth disease virus O/China99.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2.5.829

Gene vaccination to bias the immune response to amyloid-beta peptide as therapy for Alzheimer disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2.5.829

Cationic microparticles are a potent delivery system for a HCV DNA vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2.5.829

DNA vaccines: immunology, application, and optimization*

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2.5.829

DNA vaccines to attack cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2.5.829

Myth, menace or medical blessing? The clinical potential and the problems of genetic vaccines

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2.5.829

Production in Saccharomycescerevisiae of MS2 virus-like particles packaging functional heterologous mRNAs

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2.5.829

Progress in DNA-based heterologous prime-boost immunization strategies for malaria

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2.5.829

Enhanced T cell-mediated protection against malaria in human challenges by using the recombinant poxviruses FP9 and modified vaccinia virus Ankara

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2.5.829

Live Salmonella as vaccines and carriers of foreign antigenic determinants

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2.5.829

PUBLIC HEALTH: High Hopes and Dilemmas for a Cervical Cancer Vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2.5.829

Efficient delivery of DNA to dendritic cells mediated by influenza virosomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2.5.829

Liposomes as immunological adjuvants

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2.5.829

21 January 2018

Identifiers

DOI

10.1517/17425247.2.5.829

1 reference

13 August 2017

1 reference